APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA Transcriptome Profiling Test

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global RNA Transcriptome Profiling Test Industry Growth and Trends Forecast to 2032

15 April 2026104 pages

Choose your research edition.

Industry ResearchRNA Transcriptome Profiling Test Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Transcriptome Profiling Test Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal RNA Transcriptome Profiling Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Transcriptome Profiling Test Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal RNA Transcriptome Profiling Test Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global RNA Transcriptome Profiling Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNA Transcriptome Profiling Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the RNA Transcriptome Profiling Test market include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Merck KGaA, Eurofins Scientific and Pacific Biosciences of California, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global RNA Transcriptome Profiling Test market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The RNA Transcriptome Profiling Test market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global RNA Transcriptome Profiling Test market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to RNA Transcriptome Profiling Test.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global RNA Transcriptome Profiling Test market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

RNA Transcriptome Profiling Test Market by Company

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

QIAGEN N.V.

F. Hoffmann-La Roche AG

Bio-Rad Laboratories, Inc.

Merck KGaA

Eurofins Scientific

Pacific Biosciences of California, Inc.

Promega Corporation

10x Genomics

Twist Bioscience

Bruker Spatial Biology

RNA Transcriptome Profiling Test Segment by Type

Consumables

Instruments

Software

Services

RNA Transcriptome Profiling Test Segment by Application

Hospital Based Laboratories

Diagnostic Centers

Academic and Research Institutes

Contract research Organizations (CROs)

Others

RNA Transcriptome Profiling Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Transcriptome Profiling Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Transcriptome Profiling Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Transcriptome Profiling Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of RNA Transcriptome Profiling Test companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global RNA Transcriptome Profiling Test Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global RNA Transcriptome Profiling Test Market Size by Region (2021-2026) & (US$ Million) Table 3. Global RNA Transcriptome Profiling Test Market Share by Region (2021-2026) Table 4. Global RNA Transcriptome Profiling Test Market Size by Region (2027-2032) & (US$ Million) Table 5. Global RNA Transcriptome Profiling Test Market Share by Region (2027-2032) Table 6. Global RNA Transcriptome Profiling Test Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global RNA Transcriptome Profiling Test Market Size by Type (2021-2026) & (US$ Million) Table 8. Global RNA Transcriptome Profiling Test Market Size Share by Type (2021-2026) Table 9. Global RNA Transcriptome Profiling Test Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global RNA Transcriptome Profiling Test Market Size Share Forecasted by Type (2027-2032) Table 11. North America RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America RNA Transcriptome Profiling Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe RNA Transcriptome Profiling Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific RNA Transcriptome Profiling Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America RNA Transcriptome Profiling Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa RNA Transcriptome Profiling Test Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global RNA Transcriptome Profiling Test Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global RNA Transcriptome Profiling Test Market Size by Application (2021-2026) & (US$ Million) Table 23. Global RNA Transcriptome Profiling Test Market Size Share by Application (2021-2026) Table 24. Global RNA Transcriptome Profiling Test Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global RNA Transcriptome Profiling Test Market Size Share Forecasted by Application (2027-2032) Table 26. North America RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America RNA Transcriptome Profiling Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe RNA Transcriptome Profiling Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific RNA Transcriptome Profiling Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America RNA Transcriptome Profiling Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa RNA Transcriptome Profiling Test Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. RNA Transcriptome Profiling Test Industry Trends Table 37. RNA Transcriptome Profiling Test Industry Drivers Table 38. RNA Transcriptome Profiling Test Industry Opportunities and Challenges Table 39. RNA Transcriptome Profiling Test Industry Restraints Table 40. Global RNA Transcriptome Profiling Test Revenue by Company (US$ Million) & (2021-2026) Table 41. Global RNA Transcriptome Profiling Test Revenue Market Share by Company (2021-2026) Table 42. Global RNA Transcriptome Profiling Test Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global RNA Transcriptome Profiling Test Key Company Headquarters & Area Served Table 44. Global RNA Transcriptome Profiling Test Company, Product Type & Application Table 45. Global RNA Transcriptome Profiling Test Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global RNA Transcriptome Profiling Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific, Inc. Company Information Table 49. Thermo Fisher Scientific, Inc. Business Overview Table 50. Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 52. Thermo Fisher Scientific, Inc. Recent Development Table 53. Illumina, Inc. Company Information Table 54. Illumina, Inc. Business Overview Table 55. Illumina, Inc. RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 57. Illumina, Inc. Recent Development Table 58. Agilent Technologies, Inc. Company Information Table 59. Agilent Technologies, Inc. Business Overview Table 60. Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 62. Agilent Technologies, Inc. Recent Development Table 63. QIAGEN N.V. Company Information Table 64. QIAGEN N.V. Business Overview Table 65. QIAGEN N.V. RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio Table 67. QIAGEN N.V. Recent Development Table 68. F. Hoffmann-La Roche AG Company Information Table 69. F. Hoffmann-La Roche AG Business Overview Table 70. F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio Table 72. F. Hoffmann-La Roche AG Recent Development Table 73. Bio-Rad Laboratories, Inc. Company Information Table 74. Bio-Rad Laboratories, Inc. Business Overview Table 75. Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 77. Bio-Rad Laboratories, Inc. Recent Development Table 78. Merck KGaA Company Information Table 79. Merck KGaA Business Overview Table 80. Merck KGaA RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merck KGaA RNA Transcriptome Profiling Test Product Portfolio Table 82. Merck KGaA Recent Development Table 83. Eurofins Scientific Company Information Table 84. Eurofins Scientific Business Overview Table 85. Eurofins Scientific RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio Table 87. Eurofins Scientific Recent Development Table 88. Pacific Biosciences of California, Inc. Company Information Table 89. Pacific Biosciences of California, Inc. Business Overview Table 90. Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio Table 92. Pacific Biosciences of California, Inc. Recent Development Table 93. Promega Corporation Company Information Table 94. Promega Corporation Business Overview Table 95. Promega Corporation RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Promega Corporation RNA Transcriptome Profiling Test Product Portfolio Table 97. Promega Corporation Recent Development Table 98. 10x Genomics Company Information Table 99. 10x Genomics Business Overview Table 100. 10x Genomics RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. 10x Genomics RNA Transcriptome Profiling Test Product Portfolio Table 102. 10x Genomics Recent Development Table 103. Twist Bioscience Company Information Table 104. Twist Bioscience Business Overview Table 105. Twist Bioscience RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio Table 107. Twist Bioscience Recent Development Table 108. Bruker Spatial Biology Company Information Table 109. Bruker Spatial Biology Business Overview Table 110. Bruker Spatial Biology RNA Transcriptome Profiling Test Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio Table 112. Bruker Spatial Biology Recent Development Table 113. North America RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America RNA Transcriptome Profiling Test Market Size by Country (2021-2026) & (US$ Million) Table 115. North America RNA Transcriptome Profiling Test Market Share by Country (2021-2026) Table 116. North America RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America RNA Transcriptome Profiling Test Market Share Forecast by Country (2027-2032) Table 118. Europe RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe RNA Transcriptome Profiling Test Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe RNA Transcriptome Profiling Test Market Share by Country (2021-2026) Table 121. Europe RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe RNA Transcriptome Profiling Test Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific RNA Transcriptome Profiling Test Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific RNA Transcriptome Profiling Test Market Share by Country (2021-2026) Table 126. Asia-Pacific RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific RNA Transcriptome Profiling Test Market Share Forecast by Country (2027-2032) Table 128. Latin America RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America RNA Transcriptome Profiling Test Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America RNA Transcriptome Profiling Test Market Share by Country (2021-2026) Table 131. Latin America RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America RNA Transcriptome Profiling Test Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa RNA Transcriptome Profiling Test Market Share by Country (2021-2026) Table 136. Middle East & Africa RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa RNA Transcriptome Profiling Test Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. RNA Transcriptome Profiling Test Product Image Figure 3. Global RNA Transcriptome Profiling Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global RNA Transcriptome Profiling Test Market Size (2021-2032) & (US$ Million) Figure 5. Global RNA Transcriptome Profiling Test Market Share by Region: 2025 VS 2032 Figure 6. Global RNA Transcriptome Profiling Test Market Share by Region (2021-2032) Figure 7. North America RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Consumables Image Figure 13. Global Consumables Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Instruments Image Figure 15. Global Instruments Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Software Image Figure 17. Global Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Services Image Figure 19. Global Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global RNA Transcriptome Profiling Test Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global RNA Transcriptome Profiling Test Market Share by Type 2025 VS 2032 Figure 22. North America RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032) Figure 23. Europe RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032) Figure 25. Latin America RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa RNA Transcriptome Profiling Test Market Size Share by Type (2021-2032) Figure 27. Hospital Based Laboratories Image Figure 28. Global Hospital Based Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Diagnostic Centers Image Figure 30. Global Diagnostic Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Academic and Research Institutes Image Figure 32. Global Academic and Research Institutes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Contract research Organizations (CROs) Image Figure 34. Global Contract research Organizations (CROs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global RNA Transcriptome Profiling Test Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global RNA Transcriptome Profiling Test Market Share by Application 2025 VS 2032 Figure 39. North America RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032) Figure 40. Europe RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032) Figure 42. Latin America RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa RNA Transcriptome Profiling Test Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 RNA Transcriptome Profiling Test Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America RNA Transcriptome Profiling Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America RNA Transcriptome Profiling Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 49. Europe RNA Transcriptome Profiling Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe RNA Transcriptome Profiling Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 52. Asia-Pacific RNA Transcriptome Profiling Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific RNA Transcriptome Profiling Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 55. Latin America RNA Transcriptome Profiling Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America RNA Transcriptome Profiling Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 58. Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa RNA Transcriptome Profiling Test Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa RNA Transcriptome Profiling Test Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Consumables
  • Instruments
  • Software
  • Services
Applications
  • Hospital Based Laboratories
  • Diagnostic Centers
  • Academic and Research Institutes
  • Contract research Organizations (CROs)
  • Others
Companies covered
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Eurofins Scientific
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • 10x Genomics
  • Twist Bioscience
  • Bruker Spatial Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global RNA Transcriptome Profiling Test Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global RNA Transcriptome Profiling Test Market Size by Region (2021-2032)
  5. 1.4.1 Global RNA Transcriptome Profiling Test Market Size by Region (2021-2026)
  6. 1.4.2 Global RNA Transcriptome Profiling Test Market Size by Region (2027-2032)
  7. 1.5 Key Regions RNA Transcriptome Profiling Test Market Size (2021-2032)
  8. 1.5.1 North America RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa RNA Transcriptome Profiling Test Market Size Growth Rate (2021-2032)
2 RNA Transcriptome Profiling Test Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Consumables
  3. 2.1.2 Instruments
  4. 2.1.3 Software
  5. 2.1.4 Services
  6. 2.2 Global RNA Transcriptome Profiling Test Market Size by Type
  7. 2.2.1 Global RNA Transcriptome Profiling Test Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global RNA Transcriptome Profiling Test Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global RNA Transcriptome Profiling Test Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global RNA Transcriptome Profiling Test Market Size by Regions
  11. 2.3.1 North America RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa RNA Transcriptome Profiling Test Market Size Breakdown by Type (2021-2026)
3 RNA Transcriptome Profiling Test Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Based Laboratories
  3. 3.1.2 Diagnostic Centers
  4. 3.1.3 Academic and Research Institutes
  5. 3.1.4 Contract research Organizations (CROs)
  6. 3.1.5 Others
  7. 3.2 Global RNA Transcriptome Profiling Test Market Size by Application
  8. 3.2.1 Global RNA Transcriptome Profiling Test Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global RNA Transcriptome Profiling Test Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global RNA Transcriptome Profiling Test Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global RNA Transcriptome Profiling Test Market Size by Regions
  12. 3.3.1 North America RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa RNA Transcriptome Profiling Test Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 RNA Transcriptome Profiling Test Industry Trends
  2. 4.2 RNA Transcriptome Profiling Test Industry Drivers
  3. 4.3 RNA Transcriptome Profiling Test Industry Opportunities and Challenges
  4. 4.4 RNA Transcriptome Profiling Test Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by RNA Transcriptome Profiling Test Revenue (2021-2026)
  2. 5.2 Global RNA Transcriptome Profiling Test Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global RNA Transcriptome Profiling Test Key Company Headquarters & Area Served
  4. 5.4 Global RNA Transcriptome Profiling Test Company, Product Type & Application
  5. 5.5 Global RNA Transcriptome Profiling Test Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global RNA Transcriptome Profiling Test Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 RNA Transcriptome Profiling Test Players Market Share by Revenue in 2025
  9. 5.6.3 2025 RNA Transcriptome Profiling Test Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific, Inc.
  2. 6.1.1 Thermo Fisher Scientific, Inc. Company Information
  3. 6.1.2 Thermo Fisher Scientific, Inc. Business Overview
  4. 6.1.3 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific, Inc. RNA Transcriptome Profiling Test Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific, Inc. Recent Developments
  7. 6.2 Illumina, Inc.
  8. 6.2.1 Illumina, Inc. Company Information
  9. 6.2.2 Illumina, Inc. Business Overview
  10. 6.2.3 Illumina, Inc. RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Illumina, Inc. RNA Transcriptome Profiling Test Product Portfolio
  12. 6.2.5 Illumina, Inc. Recent Developments
  13. 6.3 Agilent Technologies, Inc.
  14. 6.3.1 Agilent Technologies, Inc. Company Information
  15. 6.3.2 Agilent Technologies, Inc. Business Overview
  16. 6.3.3 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Agilent Technologies, Inc. RNA Transcriptome Profiling Test Product Portfolio
  18. 6.3.5 Agilent Technologies, Inc. Recent Developments
  19. 6.4 QIAGEN N.V.
  20. 6.4.1 QIAGEN N.V. Company Information
  21. 6.4.2 QIAGEN N.V. Business Overview
  22. 6.4.3 QIAGEN N.V. RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 QIAGEN N.V. RNA Transcriptome Profiling Test Product Portfolio
  24. 6.4.5 QIAGEN N.V. Recent Developments
  25. 6.5 F. Hoffmann-La Roche AG
  26. 6.5.1 F. Hoffmann-La Roche AG Company Information
  27. 6.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 6.5.3 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche AG RNA Transcriptome Profiling Test Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 6.6 Bio-Rad Laboratories, Inc.
  32. 6.6.1 Bio-Rad Laboratories, Inc. Company Information
  33. 6.6.2 Bio-Rad Laboratories, Inc. Business Overview
  34. 6.6.3 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories, Inc. RNA Transcriptome Profiling Test Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories, Inc. Recent Developments
  37. 6.7 Merck KGaA
  38. 6.7.1 Merck KGaA Company Information
  39. 6.7.2 Merck KGaA Business Overview
  40. 6.7.3 Merck KGaA RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merck KGaA RNA Transcriptome Profiling Test Product Portfolio
  42. 6.7.5 Merck KGaA Recent Developments
  43. 6.8 Eurofins Scientific
  44. 6.8.1 Eurofins Scientific Company Information
  45. 6.8.2 Eurofins Scientific Business Overview
  46. 6.8.3 Eurofins Scientific RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eurofins Scientific RNA Transcriptome Profiling Test Product Portfolio
  48. 6.8.5 Eurofins Scientific Recent Developments
  49. 6.9 Pacific Biosciences of California, Inc.
  50. 6.9.1 Pacific Biosciences of California, Inc. Company Information
  51. 6.9.2 Pacific Biosciences of California, Inc. Business Overview
  52. 6.9.3 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pacific Biosciences of California, Inc. RNA Transcriptome Profiling Test Product Portfolio
  54. 6.9.5 Pacific Biosciences of California, Inc. Recent Developments
  55. 6.10 Promega Corporation
  56. 6.10.1 Promega Corporation Company Information
  57. 6.10.2 Promega Corporation Business Overview
  58. 6.10.3 Promega Corporation RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Promega Corporation RNA Transcriptome Profiling Test Product Portfolio
  60. 6.10.5 Promega Corporation Recent Developments
  61. 6.11 10x Genomics
  62. 6.11.1 10x Genomics Company Information
  63. 6.11.2 10x Genomics Business Overview
  64. 6.11.3 10x Genomics RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 10x Genomics RNA Transcriptome Profiling Test Product Portfolio
  66. 6.11.5 10x Genomics Recent Developments
  67. 6.12 Twist Bioscience
  68. 6.12.1 Twist Bioscience Company Information
  69. 6.12.2 Twist Bioscience Business Overview
  70. 6.12.3 Twist Bioscience RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Twist Bioscience RNA Transcriptome Profiling Test Product Portfolio
  72. 6.12.5 Twist Bioscience Recent Developments
  73. 6.13 Bruker Spatial Biology
  74. 6.13.1 Bruker Spatial Biology Company Information
  75. 6.13.2 Bruker Spatial Biology Business Overview
  76. 6.13.3 Bruker Spatial Biology RNA Transcriptome Profiling Test Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bruker Spatial Biology RNA Transcriptome Profiling Test Product Portfolio
  78. 6.13.5 Bruker Spatial Biology Recent Developments
7 North America
  1. 7.1 North America RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  3. 7.3 North America RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  3. 8.3 Europe RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  3. 10.3 South America RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa RNA Transcriptome Profiling Test Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa RNA Transcriptome Profiling Test Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa RNA Transcriptome Profiling Test Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst